OmniAb (OABI) EBT Margin Growth (1y) (2023 - 2026)
OmniAb (OABI) EBT Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 39,033.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,033.00 |
| Dec 31, 2025 | -3,276.00 |
| Sep 30, 2025 | -33,255.00 |
| Jun 30, 2025 | -20,036.00 |
| Mar 31, 2025 | 12,701.00 |
| Dec 31, 2024 | 27,444.00 |
| Sep 30, 2024 | -10,969.00 |
| Jun 30, 2024 | 5,755.00 |
| Mar 31, 2024 | -52,556.00 |
| Dec 31, 2023 | -44,261.00 |
| Sep 30, 2023 | -13,191.00 |
| Jun 30, 2023 | -8,695.00 |
| Mar 31, 2023 | 4,332.00 |